Skip to main content

Table 3 Summary of primary and comorbid conditions reported by 53,963 patients seeking medical cannabis certification across five states

From: Comparing medical cannabis use in 5 US states: a retrospective database study

Condition

Massachusetts

n = 27,892

n (%)

Colorado

n = 16,434

n (%)

Maine

n = 4591

n (%)

Connecticut

n = 2643

n (%)

Maryland

n = 2403

n (%)

Total

n = 61,379

%

Primary condition

 Chronic pain

5407

(19.4%)

12926

(78.7%)

1646

(35.9%)

42

(1.6%)

569

(23.7%)

38.8%

 Anxiety

6062

(21.7%)

5

(<0.1%)

581

(12.7%)

9

(0.3%)

487

(20.3%)

13.5%

 Post-traumatic stress disorder

1439

(5.2%)

456

(2.8%)

323

(7.0%)

1860

(70.4%)

126

(5.2%)

8.4%

 Back and neck problems

2737

(9.8%)

22

(0.1%)

590

(12.9%)

24

(0.9%)

273

(11.4%)

6.5%

 Arthritis

1785

(6.4%)

14

(0.1%)

232

(5.1%)

44

(1.7%)

142

(5.9%)

3.9%

 Insomnia

1811

(6.5%)

1

(0.0%)

169

(3.7%)

0

(0.0%)

76

(3.2%)

3.4%

 Cancer-related pain

752

(2.7%)

447

(2.7%)

84

(1.8%)

98

(3.7%)

48

(2.0%)

2.7%

 Depression

1050

(3.8%)

0

(0.0%)

58

(1.3%)

0

(0.0%)

102

(4.2%)

2.0%

 Migraines

810

(2.9%)

26

(0.2%)

136

(3.0%)

36

(1.4%)

54

(2.2%)

2.0%

 Muscle spasms

148

(0.5%)

780

(4.7%)

32

(0.7%)

0

(0.0%)

26

(1.1%)

1.7%

 ADD/ADHD

866

(3.1%)

0

(0.0%)

71

(1.5%)

0

(0.0%)

39

(1.6%)

1.6%

 Chronic nausea

248

(0.9%)

546

(3.3%)

60

(1.3%)

0

(0.0%)

16

(0.7%)

1.5%

 Fibromyalgia

448

(1.6%)

14

(0.1%)

57

(1.2%)

53

(2.0%)

28

(1.2%)

1.2%

 Headaches

292

(1.0%)

242

(1.5%)

94

(2.0%)

29

(1.1%)

15

(0.6%)

1.2%

 Spinal cord injury/disease

263

(0.9%)

0

(0.0%)

15

(0.3%)

192

(7.3%)

22

(0.9%)

0.9%

 Other

3774

(13.5%)

955

(5.8%)

443

(9.6%)

256

(9.7%)

380

(15.8%)

10.7%

Comorbid Conditions

 Anxiety

9815

(35.2%)

1226

(7.5%)

1543

(33.6%)

1534

(58.0%)

710

(29.5%)

28.3%

 Back and neck problems

7858

(28.2%)

1642

(10.0%)

1323

(28.8%)

807

(30.5%)

564

(23.5%)

23.7%

 Depression

8290

(29.7%)

481

(2.9%)

1059

(23.1%)

1014

(38.4%)

560

(23.3%)

21.9%

 Insomnia

9442

(33.9%)

740

(4.5%)

1157

(25.2%)

782

(29.6%)

491

(20.4%)

23.2%

 Chronic pain

6227

(22.3%)

1072

(6.5%)

1314

(28.6%)

653

(24.7%)

584

(24.3%)

18.2%

 Stress

7171

(25.7%)

73

(0.4%)

913

(19.9%)

947

(35.8%)

571

(23.8%)

11.2%

 Headaches

4569

(16.4%)

1339

(8.1%)

756

(16.5%)

487

(18.4%)

277

(11.5%)

14.2%

 Arthritis

5013

(18.0%)

700

(4.3%)

767

(16.7%)

452

(17.1%)

286

(11.9%)

14.0%

 Muscle spasms

3234

(11.6%)

2141

(13.0%)

668

(14.6%)

331

(12.5%)

277

(11.5%)

12.8%

 Migraines

3508

(12.6%)

692

(4.2%)

392

(8.5%)

362

(13.7%)

189

(7.9%)

9.9%

 Post-traumatic stress disorder

3265

(11.7%)

1257

(7.6%)

618

(13.5%)

114

(4.3%)

201

(8.4%)

10.0%

 ADD/ADHD

2855

(10.2%)

88

(0.5%)

366

(8.0%)

377

(14.3%)

216

(9.0%)

7.5%

 Mood disorders

2222

(8.0%)

30

(0.2%)

261

(5.7%)

308

(11.7%)

140

(5.8%)

6.0%

 Chronic nausea

1544

(5.5%)

1665

(10.1%)

350

(7.6%)

0

(0.0%)

77

(3.2%)

7.2%

 Neuropathic pain

1660

(6.0%)

165

(1.0%)

253

(5.5%)

200

(7.6%)

96

(4.0%)

4.8%

 Irritable bowel syndrome

1698

(6.1%)

82

(0.5%)

292

(6.4%)

197

(7.5%)

83

(3.5%)

4.6%

 Appetite stimulation

1875

(6.7%)

112

(0.7%)

256

(5.6%)

157

(5.9%)

102

(4.2%)

4.7%

 Fibromyalgia

967

(3.5%)

189

(1.2%)

173

(3.8%)

83

(3.1%)

48

(2.0%)

2.9%

 Spinal cord injury

928

(3.3%)

27

(0.2%)

131

(2.9%)

105

(4.0%)

63

(2.6%)

2.7%

 Obsessive compulsive behavior

904

(3.2%)

11

(0.1%)

89

(1.9%)

132

(5.0%)

45

(1.9%)

2.3%

  1. Table 3 provides a summary of the reported primary and comorbid conditions of patients seeking medical cannabis access at CB2 Insights clinics between November 2018 and March 2020 across five states. The total column includes all 61,379 patients included in the initial study for comparison, including patients from 12 states (Mahabir et al. 2020). Patients could only report one primary condition. All conditions that represented at least 2.0% of the sample in one state are listed, the remaining are grouped under “other”. Patients could report multiple comorbid conditions, but not the same comorbid condition as their primary. The top 20 are reported in the table. ADD = attention deficit disorder; ADHD = attention deficit hyperactivity disorder